PARADEEP — Paradeep Phosphates Balance Sheet
0.000.00%
- IN₹125.52bn
- IN₹162.72bn
- IN₹138.20bn
- 65
- 53
- 73
- 73
Annual balance sheet for Paradeep Phosphates, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,112 | 14,865 | 4,470 | 907 | 11,428 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 13,310 | 9,707 | 37,790 | 33,266 | 31,673 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 29,384 | 51,333 | 70,152 | 57,569 | 71,239 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 14,452 | 15,960 | 35,088 | 37,433 | 38,415 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 44,232 | 79,282 | 106,570 | 96,611 | 111,463 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 23,694 | 50,534 | 63,910 | 52,259 | 62,262 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 25,957 | 57,032 | 71,523 | 60,967 | 70,694 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 18,275 | 22,250 | 35,047 | 35,644 | 40,769 |
| Total Liabilities & Shareholders' Equity | 44,232 | 79,282 | 106,570 | 96,611 | 111,463 |
| Total Common Shares Outstanding |